AIZ
69
-7
MU
59
3
DTE
50
-6
CNP
62
10
AKAM
40
-16
MRO
42
-4
TSCO
55
5
NWSA
71
2
SYY
56
3
BAC
56
2
HSY
67
3
DUK
62
-2
PRGO
48
-2
STI
35
-11
FLS
71
2
HOG
33
2
PAYX
57
3
VZ
35
5
IR
82
2
TROW
58
2
AIZ
69
-7
MU
59
3
DTE
50
-6
CNP
62
10
AKAM
40
-16
MRO
42
-4
TSCO
55
5
NWSA
71
2
SYY
56
3
BAC
56
2
HSY
67
3
DUK
62
-2
PRGO
48
-2
STI
35
-11
FLS
71
2
HOG
33
2
PAYX
57
3
VZ
35
5
IR
82
2
TROW
58
2
Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See
Buy
67

TGTX
TG Therapeutics

Last Price:
16.61
Seasonality Move:
-2.5%

7 Day Trial

ALL ACCESS PASS

$ 7

DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon

Discover our top DeFi pick for potentially massive gains now (before it's too late).

TG Therapeutics Price Quote

$16.61
-0.01 (-1.83%)
(Updated: May 11, 2024 at 6:29 AM ET)

TG Therapeutics Key Stats

Buy
67
TG Therapeutics (TGTX) is a Buy
Day range:
$16.60 - $17.13
52-week range:
$6.46 - $33.58
Dividend yield:
0%
P/E ratio:
184.67
P/S ratio:
8.61
P/B ratio:
16.04%
Volume:
2.2M
Avg. volume:
3.7M
1-year change:
-52.23%
Market cap:
$2.6B
Revenue:
$233.7M
EPS:
$0.22

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 7.13%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went up by 12.98% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price fell by -52.23% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $101.3M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $209.8M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.04

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is $20.3M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $47.5M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$53.7M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is 19.66%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 14.18%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is 37.23%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • Editas Medicine Inc (EDIT)
    • Amicus Therapeutics Inc (FOLD)
    • Geron Corp (GERN)
    • G1 Therapeutics Inc (GTHX)
    • Mersana Therapeutics Inc (MRSN)

TG Therapeutics Dividend Yield

Data Unavailable

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -55.56%
Revenue: 713.46% 16.24%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 31.50
Upside from Last Price: 89.53%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    126.5M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22M TGTX shares are owned by insiders